Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer

The best current biomarker strategies for predicting response to immune checkpoint inhibitor (ICI) therapy fail to account for interpatient variability in response rates. The histologic tumor–stroma ratio (TSR) quantifies intratumoral stromal content and was recently found to be predictive of respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravensbergen, Cor J., Polack, Meaghan, Roelands, Jessica, Crobach, Stijn, Putter, Hein, Gelderblom, Hans, Tollenaar, Rob A. E. M., Mesker, Wilma E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616493/
https://www.ncbi.nlm.nih.gov/pubmed/34831157
http://dx.doi.org/10.3390/cells10112935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616493/
https://www.ncbi.nlm.nih.gov/pubmed/34831157
http://dx.doi.org/10.3390/cells10112935

Ejemplares similares